Updated:
Claris Capital
Claris Capital is a wholly owned subsidiary of Claris Lifesciences Limited. The company is a corporate group initiative with interests in pharmaceuticals,...
Claris Capital
Claris Capital is a wholly owned subsidiary of Claris Lifesciences Limited. The company is a corporate group initiative with interests in pharmaceuticals, healthcare, education, clean energy, and agriculture. Claris Capital focuses on investment and financial activities, having made 4 investments, including a Series A investment in Bold Care on February 11, 2025.
General information
Firm type
Private Equity
Year founded
2015
Location
Region
Asia
Country
India
City
Ahmedabad
Corporate office
6, Arista @ Eight, Satyam Marg, Behind Satyam House, Rajpath Rangoli Rd, Bodakdev, Ahmedabad- 380059, Gujarat, India
Sector focus
Frequently asked questions
Is Claris Capital a fund or a corporate balance-sheet investor?
Claris Capital is a wholly owned subsidiary of Claris Limited and invests off the corporate balance sheet. It does not operate as an independent fund with external limited partners. This structure gives the firm flexibility on holding periods and eliminates the need to raise successive fund vintages.
What investment stages does Claris Capital target?
The firm primarily targets early-stage rounds from Seed through Series B. However, it also co-invests alongside other institutional investors in later-stage growth rounds ranging from Series C up to pre-IPO, depending on the opportunity.
Where does Claris Capital's investment capital come from?
The capital is provided by Claris Limited, the parent group with over 20 years of operating history in pharmaceuticals, healthcare, education, clean energy, and agriculture. Claris Capital does not disclose targeted allocation amounts or the size of the balance-sheet facility it draws upon.
How is Claris Capital related to Claris Limited's core pharmaceutical business?
Claris Capital is a wholly owned subsidiary established to incubate and invest in new-age businesses, leveraging the parent group's operational experience. The investment team is expected to draw on Claris Limited's sector expertise in pharma and healthcare when underwriting deals, creating a strategic overlap between the venture portfolio and the parent's core industry knowledge.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: